Enanta Pharmaceuticals Inc. (ENTA)
Market Closed
27 Jul, 20:00
$
12. 73
-0.05
-0.3912%
$
303.21M Market Cap
- P/E Ratio
- Div Yield
87,566 Volume
-5.15 Eps
$ 12.78
Previous Close 
Want to track ENTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enanta Pharmaceuticals Inc. (ENTA) Statistics
Valuation metrics
Market Cap 303.21M
Enterprise value 448.4M
Trailing P/E (ttm) -4.66
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 4.29
Price/Book (mrq) 2.34
Enterprise Value/Revenue 6.48
Enterprise Value/EBITDA -9.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 132.5K
Average volume (90 days) 198.02K
Price summary
52-Week low 6.45
52-Week high 17.15
Beta -
50-Day moving average 13.09
200-Day moving average 13.53
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.9%
Operating margin -0.87%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.24
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.9
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.66
Total debt (mrq) -
Total Debt/Equity (mrq) 1.6
Current ratio (mrq) 3.84%
Book value per share (mrq) 5.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
